A family-specific linkage analysis of blood lipid response to fenofibrate in the Genetics of Lipid Lowering Drug and Diet Network (GOLDN)

Cost-effective identification of novel pharmacogenetic variants remains a pressing need in the field. Using data from the Genetics of Lipid Lowering Drugs and Diet Network, we identified genomic regions of relevance to fenofibrate response in a sample of 173 families. Our approach included a multipo...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Pharmacogenet Genomics
Egile Nagusiak: Hidalgo, Bertha, Aslibekyan, Stella, Wiener, Howard W., Irvin, Marguerite R., Straka, Robert J., Borecki, Ingrid B., Tiwari, Hemant K., Tsai, Michael Y., Hopkins, Paul N., Ordovas, Jose M., Arnett, Donna K.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2015
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4558213/
https://ncbi.nlm.nih.gov/pubmed/26203732
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FPC.0000000000000162
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak